Good evening :)
Place Order
Add to Watchlist

Samrat Pharmachem Ltd

SAMRATPH Share Price

341.001.56% (+5.25)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Materials
Commodity Chemicals
Smallcap

With a market cap of ₹105 cr, stock is ranked 2,983

High Risk

Stock is 3.76x as volatile as Nifty

SAMRATPH Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Materials
Commodity Chemicals
Smallcap

With a market cap of ₹105 cr, stock is ranked 2,983

High Risk

Stock is 3.76x as volatile as Nifty

SAMRATPH Performance & Key Metrics

SAMRATPH Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
14.821.620.29%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
26.593.351.26%

SAMRATPH Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

SAMRATPH Company Profile

Samrat Pharmachem Limited is engaged in the production of pharmaceutical chemicals like Iodine salts and Bromine salts. The Company's finished products are used in various industries, including pharmaceuticals, chemicals, food, fertilizer and salt.

SAMRATPH Similar Stocks (Peers)

Compare with peers Compare with peers 

SAMRATPH Similar Stocks (Peers)

Compare with peers Compare with peers 
Solar Industries India Ltd
SOLARINDS
PE Ratio
127.93
127.93
1Y Return
73.50%
73.50%
Buy Reco %
80.00
80.00
Linde India Ltd
LINDEINDIA
PE Ratio
131.55
131.55
1Y Return
25.12%
25.12%
Buy Reco %
50.00
50.00
Deepak Nitrite Ltd
DEEPAKNTR
PE Ratio
37.39
37.39
1Y Return
27.28%
27.28%
Buy Reco %
60.00
60.00
Sumitomo Chemical India Ltd
SUMICHEM
PE Ratio
49.32
49.32
1Y Return
0.89%
0.89%
Buy Reco %
100.00
100.00
Himadri Speciality Chemical Ltd
HSCL
PE Ratio
40.03
40.03
1Y Return
9.57%
9.57%
Buy Reco %
100.00
100.00
Compare with Peers

SAMRATPH Forecast

SAMRATPH Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

SAMRATPH

SAMRATPH

Income

Balance Sheet

Cash Flow

SAMRATPH Income Statement

SAMRATPH Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 20.45%, vs industry avg of 8.41%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.15% to 0.21%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 6.9%, vs industry avg of 0.11%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue72.9093.19111.60138.03179.48222.38311.13282.96286.83286.84
Raw Materialssubtract62.9582.43103.53131.80162.02190.23288.00265.48275.62275.62
Power & Fuel Costsubtract0.630.820.730.911.121.341.461.37
Employee Costsubtract0.760.850.941.001.050.961.071.11
Selling & Administrative Expensessubtract3.112.312.091.831.832.463.103.36
Operating & Other expensessubtract1.600.580.67-4.704.352.52-6.927.79
Depreciation/Amortizationsubtract0.430.410.420.430.490.590.640.650.650.66
Interest & Other Itemssubtract0.630.861.060.981.280.671.230.690.670.68
Taxes & Other Itemssubtract1.021.700.621.552.016.425.900.362.772.78
EPS5.7310.454.9813.6917.2555.6453.896.9623.0222.98
DPS0.000.000.000.000.001.001.001.001.001.00
Payout ratio0.000.000.000.000.000.020.020.140.040.04
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

SAMRATPH Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

SAMRATPH Stock Peers

SAMRATPH Past Performance & Peer Comparison

SAMRATPH Past Performance & Peer Comparison

Comparing 3 stocks from 
MaterialsCommodity Chemicals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Samrat Pharmachem Ltd14.771.620.29%
Solar Industries India Ltd127.9345.140.06%
Linde India Ltd131.5517.25—
Deepak Nitrite Ltd37.395.410.39%

SAMRATPH Stock Price Comparison

Compare SAMRATPH with any stock or ETF
Compare SAMRATPH with any stock or ETF
SAMRATPH
Loading...

SAMRATPH Holdings

SAMRATPH Shareholdings

SAMRATPH Promoter Holdings Trend

SAMRATPH Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

SAMRATPH Institutional Holdings Trend

SAMRATPH Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

SAMRATPH Shareholding Pattern

SAMRATPH Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding49.09%0.00%0.00%3.24%47.67%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

SAMRATPH Shareholding History

SAMRATPH Shareholding History

Dec '23MarJunSepDec '24Mar3.24%3.24%3.24%3.24%3.24%3.24%

SAMRATPH Insider Trades & Bulk Stock Deals

SAMRATPH Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing SAMRATPH stock

smallcases containing SAMRATPH stock

Looks like this stock is not in any smallcase yet.

SAMRATPH Events

SAMRATPH Events

SAMRATPH Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

SAMRATPH Dividend Trend

No dividend trend available

SAMRATPH Upcoming Dividends

SAMRATPH Upcoming Dividends

No upcoming dividends are available

SAMRATPH Past Dividends

SAMRATPH Past Dividends

Cash Dividend

Ex DateEx DateSep 19, 2024

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 19, 2024

Cash Dividend

Ex DateEx DateSep 18, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 18, 2023

Cash Dividend

Ex DateEx DateSep 22, 2022

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 22, 2022

SAMRATPH Stock News & Opinions

SAMRATPH Stock News & Opinions

Corporate
Samrat Pharmachem AGM scheduled

Samrat Pharmachem announced that the 33th Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Board of Samrat Pharmachem recommends final dividend

Samrat Pharmachem announced that the Board of Directors of the Company at its meeting held on 30 May 2025, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Samrat Pharmachem reports standalone net loss of Rs 0.40 crore in the March 2025 quarter

Net loss of Samrat Pharmachem reported to Rs 0.40 crore in the quarter ended March 2025 as against net profit of Rs 1.40 crore during the previous quarter ended March 2024. Sales declined 13.88% to Rs 71.20 crore in the quarter ended March 2025 as against Rs 82.68 crore during the previous quarter ended March 2024. For the full year,net profit rose 229.17% to Rs 7.11 crore in the year ended March 2025 as against Rs 2.16 crore during the previous year ended March 2024. Sales rose 1.52% to Rs 285.86 crore in the year ended March 2025 as against Rs 281.58 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales71.2082.68 -14 285.86281.58 2 OPM %0.181.66 -3.580.88 - PBDT-0.201.56 PL 10.533.17 232 PBT-0.361.40 PL 9.882.52 292 NP-0.401.40 PL 7.112.16 229 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Samrat Pharmachem to table results

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Samrat Pharmachem standalone net profit rises 717.65% in the December 2024 quarter

Net profit of Samrat Pharmachem rose 717.65% to Rs 2.78 crore in the quarter ended December 2024 as against Rs 0.34 crore during the previous quarter ended December 2023. Sales rose 3.23% to Rs 63.66 crore in the quarter ended December 2024 as against Rs 61.67 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales63.6661.67 3 OPM %6.570.18 - PBDT4.080.30 1260 PBT3.910.14 2693 NP2.780.34 718 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Samrat Pharmachem to declare Quarterly Result

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Samrat Pharmachem reports standalone net profit of Rs 2.66 crore in the September 2024 quarter

Net profit of Samrat Pharmachem reported to Rs 2.66 crore in the quarter ended September 2024 as against net loss of Rs 0.19 crore during the previous quarter ended September 2023. Sales declined 12.00% to Rs 70.17 crore in the quarter ended September 2024 as against Rs 79.74 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales70.1779.74 -12 OPM %4.800.28 - PBDT3.690.39 846 PBT3.520.23 1430 NP2.66-0.19 LP Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Samrat Pharmachem announces board meeting date

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 November 2024.Powered by Capital Market - Live

8 months agoCapital Market - Live
Earnings
Samrat Pharmachem standalone net profit rises 239.34% in the June 2024 quarter

Net profit of Samrat Pharmachem rose 239.34% to Rs 2.07 crore in the quarter ended June 2024 as against Rs 0.61 crore during the previous quarter ended June 2023. Sales rose 40.61% to Rs 80.82 crore in the quarter ended June 2024 as against Rs 57.48 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales80.8257.48 41 OPM %3.191.34 - PBDT2.980.91 227 PBT2.820.75 276 NP2.070.61 239 Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Samrat Pharmachem Ltd (SAMRATPH) today?

    The share price of SAMRATPH as on 20th June 2025 is ₹341. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Samrat Pharmachem Ltd (SAMRATPH) share?

    The past returns of Samrat Pharmachem Ltd (SAMRATPH) share are
    • Past 1 week: -2.58%
    • Past 1 month: -9.53%
    • Past 3 months: 5.46%
    • Past 6 months: -15.05%
    • Past 1 year: -3.32%
    • Past 3 years: -10.97%
    • Past 5 years: 369.37%

  3. What are the peers or stocks similar to Samrat Pharmachem Ltd (SAMRATPH)?

    The peers or stocks similar to Samrat Pharmachem Ltd (SAMRATPH) include:

  4. What is the dividend yield % of Samrat Pharmachem Ltd (SAMRATPH) share?

    The current dividend yield of Samrat Pharmachem Ltd (SAMRATPH) is 0.29.

  5. What is the market cap of Samrat Pharmachem Ltd (SAMRATPH) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Samrat Pharmachem Ltd (SAMRATPH) is ₹105.19 Cr as of 20th June 2025.

  6. What is the 52 week high and low of Samrat Pharmachem Ltd (SAMRATPH) share?

    The 52-week high of Samrat Pharmachem Ltd (SAMRATPH) is ₹646 and the 52-week low is ₹302.05.

  7. What is the PE and PB ratio of Samrat Pharmachem Ltd (SAMRATPH) stock?

    The P/E (price-to-earnings) ratio of Samrat Pharmachem Ltd (SAMRATPH) is 14.77. The P/B (price-to-book) ratio is 1.62.

  8. Which sector does Samrat Pharmachem Ltd (SAMRATPH) belong to?

    Samrat Pharmachem Ltd (SAMRATPH) belongs to the Materials sector & Commodity Chemicals sub-sector.

  9. How to buy Samrat Pharmachem Ltd (SAMRATPH) shares?

    You can directly buy Samrat Pharmachem Ltd (SAMRATPH) shares on Tickertape. Simply sign up, connect your demat account and place your order.